Xin Wang
  • Stanford University
Research focus
  • Microbiology
  • 1 Author merit


Ph.D. in Human Retrovirology, Division of Antiviral Chemotherapy, Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, 2003

Current position

He is a Research Associate in Department of Genetics, Stanford University School of Medicine. His research focuses on the profiling of novel protein-metabolite interaction for antiviral & anticancer therapeutics development.


  1. Li, X.*, Wang, X.* and Snyder, M. (2013). Systematic investigation of protein-small molecule interactions. IUBMB Life 65(1): 2-8. (*These authors made equal contributions to the work)
  2. Wang, X., Tanaka, H., Baba, M. and Cheng, Y.-C. (2009). Study of the retention of metabolites of 4′-Ed4T, a novel anti-HIV-1 thymidine analog, in cells. Antiviral Research 82(2): A27.
  3. Wang, X., Uto, T., Akagi, T., Akashi, M. and Baba, M. (2008). Induction of Potent and Specific Humoral and Cellular Immune Responses by Poly(γ-Glutamic Acid) Nanoparticles as an Efficient Antigen Delivery System and Adjuvant. J Med Virol 80: 11-19.
  4. Wang, X., Akagi, T., Akashi, M. and Baba, M. (2007). Development of core-corona type polymeric nanoparticles as an anti-HIV-1 vaccine. Mini-Reviews in Organic Chemistry 4(1): 51-59.
  5. Wang, X., Uto, T., Akagi, T., Akashi, M. and Baba, M. (2007). Induction of potent CD8+ T-cell responses by novel biodegradable nanoparticles carrying human immunodeficiency virus type 1 gp120. J Virol 81(18): 10009-10016.
  6. Wang, X. and Baba, M. (2005). The role of breast cancer resistance protein (BCRP/ABCG2) in cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors. Antivir Chem Chemother 16(4): 213-216.
  7. Wang, X., Uto, T., Sato, K., Ide, K., Akagi, T., Okamoto, M., Kaneko, T., Akashi, M. and Baba, M. (2005). Potent activation of antigen-specific T cells by antigen-loaded nanospheres. Immunol Lett 98(1): 123-130.
  8. Wang, X., Nitanda, T., Shi, M., Okamoto, M., Furukawa, T., Sugimoto, Y., Akiyama, S. and Baba, M. (2004). Induction of cellular resistance to nucleoside reverse transcriptase inhibitors by the wild-type breast cancer resistance protein. Biochem Pharmacol 68(7): 1363-1370.
  9. Wang, X., Furukawa, T., Nitanda, T., Okamoto, M., Sugimoto, Y., Akiyama, S. and Baba, M. (2003). Breast cancer resistance protein (BCRP/ABCG2) induces cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors. Mol Pharmacol 63(1): 65-72.
  10. Wang, X., Miyake, H., Okamoto, M., Saito, M., Fujisawa, J.-I., Tanaka, Y., Izumo, S. and Baba, M. (2002). Inhibition of the tax-dependent human T-lymphotropic virus type I replication in persistently infected cells by the fluoroquinolone derivative K-37. Molecular pharmacology 61(6): 1359-1365.
1 Protocol published
Amplification of HIV-1 Infectious Virus in BL3 Lab
Author:  Xin Wang, date: 03/05/2012, view: 8329, Q&A: 0
This method is used for making high titer human immunodeficiency virus type-1 (HIV-1) virus stock for subsequent infection assays. The amplification of T-tropic HIV-1 virus (IIIB strain) uses the CD4+ T cell line H9.
您可以切换至中文站点,以获得适用于中国用户的内容 中文站点
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.